Christophe Leboeuf
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
3D co-culture model of tumor spheroid and endothelial cells unveils ccRCC aberrant vasculature and distinct sensitivity to targeted treatments.
Journal: Angiogenesis
Published: January 09, 2026
Photodynamic Therapy Using Pulsed-Laser Irradiation of Gold Nanoparticles for the Treatment of Cancers with High Basal Oxidative Stress.
Journal: Nano letters
Published: August 29, 2025
Targeting the activated allosteric conformation of the endothelin receptor B in melanoma with an antibody-drug conjugate: mechanisms and therapeutic efficacy.
Journal: BJC reports
Published: July 04, 2024
A Sub-Group of Kidney-Transplant Recipients with Highly Aggressive Squamous Cell Carcinoma Expressing Phosphorylated Serine392p53.
Journal: International journal of molecular sciences
Published: November 28, 2023
PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers.
Journal: Clinical and translational medicine
Published: October 13, 2023
Ultrasound assessment is linked to histological vein wall thickness in chronic venous disease.
Journal: Phlebology
Published: February 28, 2023
Metastatic clear-cell renal cell carcinoma: a frequent NOTCH1 mutation predictive of response to anti-NOTCH1 CB-103 treatment.
Journal: Experimental hematology & oncology
Published: December 21, 2022
In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell-Related Injury.
Journal: HemaSphere
Published: November 03, 2022
BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome.
Journal: International journal of molecular sciences
Published: July 25, 2021
Last Updated: 09/26/2026